Bacterial peptide provides new insight into common tumor suppressor

User rating: 4 / 5 after 1 vote(s)

Scientists have identified a new antitumor drug that might prove useful in developing treatments for a multiple human cancers. The research, published by Cell Press in the July 8 issue of the journal Cancer Cell, advances the understanding of one of the most frequently disrupted tumor suppressor proteins in human cancer and provides new insight into the regulation of the complex process of cellular protein degradation under normal and pathological conditions.


Full story »

All News summaries from Medicine & Health news
All News summaries for July 07, 2008

Cholera outbreak kills 20 in northern Nigeria

Oct 11, 2008 | User rating: not rated yet
A cholera outbreak has claimed 20 lives in northern Nigeria's Kano state in the last week, officials and residents said Saturday.

US controls bird flu vaccines over bioweapon fears

Oct 11, 2008 | User rating: not rated yet
(AP) -- When Indonesia's health minister stopped sending bird flu viruses to a research laboratory in the U.S. for fear Washington could use them to make biological weapons, Defense Secretary Robert Gates ...

Limit on cold remedies for kids was FDA's idea

Oct 11, 2008 | User rating: not rated yet
(AP) -- When drug makers made a surprise announcement this week that they no longer recommend cough and cold remedies for youngsters under 4, they didn't let on that it was the government's idea.

Just a numbers game? Making sense of health statistics

Oct 10, 2008 | User rating: not rated yet
Presidential candidates use them to persuade voters, drug companies use them to sell their products, and the media spin them in all kinds of ways, but nobody - candidates, reporters, let alone health consumers - understands ...

Statins may prevent miscarriages

Oct 10, 2008 | User rating: not rated yet
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study ...